Epibiotech Co., Ltd. (XKON:446440)
13,950
+60 (0.43%)
At close: Jul 9, 2026
24.78% (1Y)
| Market Cap | 32.13B +37.4% |
| Revenue (ttm) | 449.62M +15.9% |
| Net Income | -5.06B |
| EPS | -2,966.00 |
| Shares Out | 2.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12 |
| Open | 13,500 |
| Previous Close | 13,890 |
| Day's Range | 13,500 - 13,950 |
| 52-Week Range | 10,300 - 20,900 |
| Beta | 0.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |